It is believed that IGF-1 stimulates macrosomia via mammalian target of rapamycin (mTOR) activation and the subsequent increase in essential and non-essential amino acid transporters in the placenta of women with GDM.112. This evidence concerns the gene IGF1 and gestational diabetes.